142 results
8-K
EX-99.1
SCLX
Scilex Holding Company
30 May 24
Regulation FD Disclosure
5:16pm
, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today sends a letter to both the U.S … products for the treatment of acute and chronic pain. Scilex targets indications with high unmet needs and large market opportunities with non-opioid
8-K
EX-99.1
SCLX
Scilex Holding Company
24 May 24
Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company
9:30am
for the treatment of acute and chronic pain, today sends a letter to the U.S. House of Representatives on illegal market manipulation of the common stock … -generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain
424B3
SCLX
Scilex Holding Company
13 May 24
Prospectus supplement
4:18pm
pain management products for the treatment of acute and chronic pain. The Company was originally formed in 2019 and currently has five wholly owned … % (“SP-103”), a next-generation, triple-strength formulation of ZTlido, for the treatment of chronic neck pain and for which the Company completed
424B3
SCLX
Scilex Holding Company
13 May 24
Prospectus supplement
4:15pm
pain management products for the treatment of acute and chronic pain. The Company was originally formed in 2019 and currently has five wholly owned … % (“SP-103”), a next-generation, triple-strength formulation of ZTlido, for the treatment of chronic neck pain and for which the Company completed
8-K
EX-99.1
bqf6hsrm g45d
13 May 24
Regulation FD Disclosure
9:00am
424B3
ninm33fcp 0cj
25 Apr 24
Prospectus supplement
4:35pm
424B3
u6j rqdabf5
25 Apr 24
Prospectus supplement
4:33pm
8-K
EX-99.2
xjo8 sezr
25 Apr 24
Scilex Holding Company Announces $15 Million Registered Direct Offering
4:30pm
8-K
EX-99.1
udnn v3qmggj1v
25 Apr 24
Scilex Holding Company Announces $15 Million Registered Direct Offering
4:30pm
424B5
gu36hq
25 Apr 24
Prospectus supplement for primary offering
6:27am
8-K
EX-99.1
njtds b36p
16 Apr 24
Results of Operations and Financial Condition
4:06pm
424B3
bnb4 nc6c
2 Apr 24
Prospectus supplement
5:20pm
424B3
zj8dz0
2 Apr 24
Prospectus supplement
5:19pm
POS AM
63getfriw13 k7s
27 Mar 24
Prospectus update (post-effective amendment)
5:30pm
POS AM
qrtv7f ukz5tiy35v05
27 Mar 24
Prospectus update (post-effective amendment)
5:29pm
424B3
wviiwypm65x q8eaj7hx
27 Mar 24
Prospectus supplement
4:18pm
424B3
b34y5g
27 Mar 24
Prospectus supplement
4:13pm
8-K
EX-99.1
8o39ty ai
27 Mar 24
Other Events
1:37pm
424B3
yh6i7h8kk2kb6 1agp8e
22 Mar 24
Prospectus supplement
5:18pm